Today: 9 June 2026
Strategy stock jumps on MSCI reprieve for bitcoin-treasury firms — but a key limit stays
7 January 2026
2 mins read

Strategy stock jumps on MSCI reprieve for bitcoin-treasury firms — but a key limit stays

NEW YORK, Jan 7, 2026, 10:31 EST

  • MSCI said it will not exclude digital asset treasury companies from its indexes in the February 2026 review, but will open a wider consultation
  • Strategy shares rose in early trade after the decision, though bitcoin’s slip pared gains
  • MSCI said it will freeze some inputs that drive index weights for affected stocks and pause new additions and size shifts

Shares of Strategy rose on Wednesday after MSCI shelved a plan that could have pushed the bitcoin-heavy company out of key stock indexes. The stock was last up about 3.2% in morning trading, trimming earlier gains as bitcoin slipped.

The decision matters because index membership can translate into steady demand from funds that track benchmarks. Investors had worried a rule change would force passive portfolios to sell, turning a methodology debate into a near-term trading event.

MSCI said it has decided “not to implement” the proposed exclusion of so-called digital asset treasury companies in the February 2026 index review, and will instead open a broader consultation on “non-operating companies.” For now, MSCI said affected stocks stay in, but it will not raise measures like the “Number of Shares” and inclusion factors — inputs it uses to set index weights and investable share counts — and it will defer new additions and size-category moves. https://app2.msci.com/webapp/index_ann/Doc…

Digital asset treasury companies, often called DATCOs, are listed firms that hold tokens such as bitcoin and ether as main treasury assets, offering investors a stock-market proxy for crypto exposure. The trade surged in 2025, but the shares have stayed jumpy with coin prices and a still-messy accounting debate over whether these firms should be valued as operating businesses or as holding vehicles.

Owen Lau, an analyst at Clear Street, said MSCI’s pause “removes a material near-term technical risk” for stocks that trade as crypto proxies. He said the most likely path is that MSCI “grandfather” existing DATCOs already in its indexes.

Mike O’Rourke, chief market strategist at JonesTrading, said MSCI’s decision points to another, broader consultation, and he suspects any exclusion is “postponed until later in the year.” The open question is whether index providers ultimately decide these firms look more like investment funds than operating companies.

MSCI said on Tuesday it would maintain the existing treatment of companies on its preliminary DATCO list, defined as those whose digital asset holdings account for 50% or more of total assets. Strategy, formerly MicroStrategy, called the decision “a strong outcome for neutral indexing and economic reality” in a post on X, after its shares jumped about 6% in after-hours trade; the stock fell about 47.5% in 2025. https://www.reuters.com/business/msci-drop…

In an earlier consultation document, MSCI listed Strategy among potentially impacted securities, alongside names such as Mara Holdings, Hut 8 and Japan’s Metaplanet. MSCI has said it may update that preliminary list as company disclosures change.

Even without an outright removal, the freeze MSCI outlined can still bite. Investors.com reported the rule set limits how much index weights can grow through share issuance, a sensitive point for Strategy given its reliance on capital raises to keep buying bitcoin.

Stock Market Today

  • Top 3 TSX Penny Stocks Under CA$10M Market Cap with Growth Potential
    June 9, 2026, 4:07 PM EDT. Canadian penny stocks on the TSX offer investors high-risk, high-reward opportunities amid stable interest and inflation. Naughty Ventures Corp. (CA$10.07M market cap) is exploring copper mineralization in Newfoundland; despite no revenue, it posted CA$5.31 million profit for fiscal year ending January 2026 but faces auditor concerns on going concern status. GoGo AI Network Inc. (CA$17.42M) focuses on healthcare technology with CA$4.48 million revenue from pharmaceuticals, recently profitable and debt-free, supported by strategic board additions. Both companies show balance sheet strength and potential for growth, though investors should weigh risks common to penny stocks.

Latest articles

POET Technologies Shares Drop; AI Photonics Trade Faces Pressure

POET Technologies Shares Drop; AI Photonics Trade Faces Pressure

9 June 2026
POET Technologies plunged 13% to $10.65 as renewed class-action reminders and April’s Marvell/Celestial AI order cancellation kept legal and execution risks in focus, outweighing a $50 million Lumilens order and $400 million financing, while broader AI chip stocks also slumped.
Uranium Energy Drops 17% After Reporting Q3 Loss

Uranium Energy Drops 17% After Reporting Q3 Loss

9 June 2026
Uranium Energy shares plunged 17% to $10.43 after reporting a wider Q3 net loss of $52.3 million and no uranium inventory sales, overshadowing the start of production at Burke Hollow; heavy volume and a sharper drop than peers reflected investor concerns over execution risks and near-term earnings despite strong cash and no debt.
Elong Power Stock Rips 58%, Small Nasdaq Battery Play Goes Wild

Elong Power Stock Rips 58%, Small Nasdaq Battery Play Goes Wild

9 June 2026
Elong Power shares soared 58.3% to $1.22 in heavy Nasdaq trading, with volume topping 123 million, after a recent $6 million unit offering at $1.30 and a March 1-for-80 reverse split; despite the rally, the stock remained below the recent offering price, with filings showing a $5.57 million net loss for 2025, a $14 million working-capital deficit, and warnings of possible further dilution if more capital is needed.
Intel stock today: INTC steadies before the bell as CES “Panther Lake” chips put 18A under the microscope
Previous Story

Intel stock today: INTC steadies before the bell as CES “Panther Lake” chips put 18A under the microscope

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings
Next Story

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

Go toTop